Cleveland Clinic Genome Center researchers have unraveled how immune cells called microglia can transform and drive harmful ...
Mizuho Securities analyst Graig Suvannavejh has maintained their bullish stance on VIGL stock, giving a Buy rating on December 3.Pick the best ...
Building on results from previous studies, Tahirovic and colleagues focused on the "microglia": these cells belong to the ...
In healthy brains, immune cells called microglia patrol for damage, clearing away debris and harmful proteins. But in the presence of the APOE4 protein—the most important genetic risk factor for ...
Scientists report on new insights into the mechanisms of 'Niemann-Pick type C' (NPC), a rare neurodegenerative disease associated with dementia that can manifest as early as childhood. Their findings, ...
A decline in motor skills is a hallmark of Parkinson's disease, regularly taking the form of slowness, rigidity, and tremors.
New research reveals that fetuses can mount immune responses against infections long before birth, challenging the assumption that they rely solely on maternal immunity.
Vigil Neuroscience's stock dropped after Alector's AL002 failed in Alzheimer's, raising concerns about VG-3927's efficacy.
This valuable study investigates the signaling pathways regulating retina regeneration. Solid evidence shows that the sphingosine-1-phosphate (S1P) signaling pathway is inhibited following retinal ...
Analysis of human brain tissue revealed differences in how immune cells behave in brains with Alzheimer's disease compared to ...
In a new study from Texas A & M University College of Medicine, researchers have used a nasal spray to target microglia and ...